Impact of pharmacist interventions on medication errors in hospitalized pediatric patients: a systematic review and

Lina Mohammad Naseralallah1, Tarteel Ali Hussain1, Myriam Jaam2

  • 1College of Pharmacy, QU Health, Qatar University, Doha, Qatar.

Insights

Clinical pharmacist interventions significantly reduce medication errors in hospitalized children. This review highlights pharmacist involvement as a key strategy for improving pediatric patient safety and preventing adverse drug events.

Area of Science:

  • Pediatric Pharmacology
  • Patient Safety
  • Clinical Pharmacy Practice

Background:

  • Medication errors are preventable adverse events impacting patient care.
  • Pediatric patients are particularly susceptible to medication errors due to unique physiological and developmental factors.
  • Clinical pharmacists play a crucial role in mitigating medication errors.

Purpose of the Study:

  • To systematically evaluate the effectiveness of clinical pharmacist interventions in reducing medication error rates among hospitalized pediatric patients.
  • To provide both qualitative and quantitative data on the impact of pharmacist-led interventions.

Main Methods:

  • A comprehensive search of major databases (PubMed, EMBASE, Cochrane, Google Scholar) was conducted up to February 2020.
  • Included observational and interventional studies underwent independent review, data extraction, and quality assessment using the Crowe Critical Appraisal Tool.
  • A meta-analysis was performed using a random-effects model to calculate odds ratios (ORs) for medication error rates.

Main Results:

  • Nineteen studies were reviewed, with 6 studies involving 29,291 pediatric patients included in the meta-analysis.
  • Common pharmacist interventions included educational sessions, prescription reviews, and participation in patient care rounds.
  • Pharmacist involvement demonstrated a significant reduction in overall medication error rates (OR 0.27; 95% CI 0.15 to 0.49).

Conclusions:

  • Clinical pharmacist interventions are highly effective in decreasing medication error rates in hospitalized pediatric populations.
  • Integrating clinical pharmacists into pediatric care settings is a vital strategy for enhancing patient safety.
  • These findings support the expansion of clinical pharmacy services in pediatric healthcare to minimize medication-related harm.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
133
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
149
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
177
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
139